{"version":"1.0","type":"link","title":"Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.","author_name":"Jhaveri K 외","author_url":"https://prs-insight.online/author/Jhaveri%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/77423","thumbnail_width":1200,"thumbnail_height":630}